Irban OD 15 Tablet PR
Marketer
Glenmark Pharmaceuticals Ltd
Salt Composition
Ivabradine (15mg)
Overview Irban OD 15 Tablet PR
Irban OD 15 Tablet PR treats angina pectoris (chest pain stemming from heart problems) and chronic congestive heart failure. It improves cardiac function by reducing heart rate, thus alleviating chest discomfort and minimizing hospital readmissions for heart failure. Dosage is condition-specific. Because treatment for these conditions is typically lifelong, discontinuation requires physician consultation. Consistent daily ingestion with food is recommended. Overdosage can lead to bradycardia (slow heart rate), fatigue, and shortness of breath; seek immediate medical attention if this occurs. Common side effects include transient visual disturbances, bradycardia, hypertension, atrial fibrillation, vertigo, blurred vision, and electrocardiographic alterations. Serious adverse events like syncope (fainting) and significant arrhythmias necessitate urgent medical care. Refrain from driving until the drug's effects are known. Contraindicated in patients with severe hepatic impairment, resting bradycardia, cardiac arrhythmias, hypotension, or recently exacerbated heart failure. Interactions exist with certain antihypertensives, antifungals, and antiretrovirals. Avoid use during pregnancy, attempts at conception, or breastfeeding.
Primary Ingredients of Irban OD 15 Tablet PR
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Irban OD 15 Tablet PR
Managing angina pectoris and heart failure.
Major Benefits of Irban OD 15 Tablet PR:
Always follow your physician's instructions or consult the product label for proper administration. Consume Irban OD 15 Tablet PR with a meal.
Common Side effects of Irban OD 15 Tablet PR:
- Slow heart rate
- Luminous phenomena (Enhanced brightness)
- High blood pressure
- Atrial fibrillation
- Dizziness
- Blurred vision
- ECG changes
How to use Irban OD 15 Tablet PR:
Follow your physician's instructions or consult the product label for dosage information. Ingest Irban OD 15 Tablet PR with a meal.
How Irban OD 15 Tablet PR works:
Irban OD 15 Tablet PR is a drug that decreases cardiac rate. Its mechanism of action involves reducing the heart's rate, thereby lessening its oxygen demand. This ultimately improves the heart's functional efficiency.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Irban OD 15 Tablet PR has unknown safety implications. Seek medical advice before combining them.
PregnancyUNSAFE
Using Irban OD 15 Tablet PR during pregnancy poses a substantial risk. Pregnant individuals should consult their physician immediately, as research in both animals and pregnant women has revealed considerable harm to the unborn child.
Breast feedingUNSAFE
The use of Irban OD 15 Tablet PR while breastfeeding is contraindicated due to potential infant toxicity. Evidence indicates a risk of harmful effects to the nursing infant.
DrivingUNSAFE
Driving ability may be impaired by Irban OD 15 Tablet PR, which can induce side effects. These side effects may include temporary visual disturbances, primarily phosphenes. The potential for such visual disturbances should be considered, particularly during nighttime driving.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Irban OD 15 Tablet PR. Dosage modification may be necessary; physician consultation is advised. Data regarding Irban OD 15 Tablet PR use in this patient population is limited.
LiverCAUTION
Patients with liver impairment should exercise caution when using Irban OD 15 Tablet PR; dosage modification may be necessary. Consult a physician for guidance. Irban OD 15 Tablet PR is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Irban OD 15 Tablet PR :
Omit any missed Irban OD 15 Tablet PR dose and resume your regular dosing regimen. Avoid taking a double dose.
Facts to Know About Irban OD 15 Tablet PR
| Label | Value |
|---|---|
| Chemical Type | Benzazepine-based compound |
| Developing Habits | No. |
| Treatment Category | Heart |
| Actions | Sinoatrial node I<sub>f</sub> sodium channel blockers |





